Nanocrystals seed calcification in more ways than one

Slides:



Advertisements
Similar presentations
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Advertisements

Melamine toxicity: one more culprit in calcium kidney lithiasis
Volume 82, Issue 10, Pages (November 2012)
Volume 82, Issue 1, Pages (July 2012)
Dylan Burger, Adeera Levin  Kidney International 
Volume 88, Issue 4, Pages (October 2015)
Volume 80, Issue 7, Pages (October 2011)
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
Verotoxin biology: molecular events in vascular endothelial injury
Volume 85, Issue 3, Pages (March 2014)
Volume 73, Issue 9, Pages (May 2008)
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Volume 72, Issue 6, Pages (September 2007)
Volume 86, Issue 4, Pages (October 2014)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 95, Issue 4, Pages (April 2019)
Volume 73, Issue 4, Pages (February 2008)
Veerle P. Persy, Marc D. McKee  Kidney International 
Volume 87, Issue 2, Pages (February 2015)
Dendritic cells and innate immunity in kidney transplantation
Pieter Evenepoel, Björn K. Meijers  Kidney International 
Bisphosphonate safety and efficacy in chronic kidney disease
Oxidative stress, AGE, and atherosclerosis
Volume 83, Issue 5, Pages (May 2013)
Volume 88, Issue 4, Pages (October 2015)
Melamine toxicity: one more culprit in calcium kidney lithiasis
Qingqing Wei, Zheng Dong  Kidney International 
Volume 67, Pages S51-S58 (June 2005)
A physician's perseverance uncovers problems in a key nephrology study
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 85, Issue 5, Pages (May 2014)
Volume 70, Issue 6, Pages (September 2006)
Volume 87, Issue 3, Pages (March 2015)
Volume 56, Issue 4, Pages (October 1999)
Volume 54, Issue 2, Pages (August 1998)
Nephrology Crossword: Glomerulonephritis
Volume 75, Issue 9, Pages (May 2009)
On vascular calcification and plasma levels of pyrophosphate
Volume 87, Issue 5, Pages (May 2015)
New paradigms in cell death in human diabetic nephropathy
Volume 73, Issue 9, Pages (May 2008)
Immunity unmasks APOL1 in collapsing glomerulopathy
The emerging role of phosphate in vascular calcification
Does equal care give equal outcomes?
The vascular secret of Klotho
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Volume 75, Issue 12, Pages (June 2009)
Volume 83, Issue 4, Pages (April 2013)
Volume 70, Issue 6, Pages (September 2006)
Volume 71, Issue 9, Pages (May 2007)
The complex field of interplay between vasoactive agents
Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller 
Volume 75, Issue 7, Pages (April 2009)
The international realities of live donor kidney transplantation
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Cell biological and physicochemical aspects of arterial calcification
Volume 80, Issue 9, Pages (November 2011)
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?  Ellen G. Neven, Marc E. De Broe, Patrick.
Volume 74, Issue 10, Pages (November 2008)
Global trends in the rates of living kidney donation
Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation  W. Charles O'Neill, Amy.
Vascular calcification: Not so crystal clear
The Ebf1 knockout mouse and glomerular maturation
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in.
Sclerostin and DKK1: new players in renal bone and vascular disease
Presentation transcript:

Nanocrystals seed calcification in more ways than one Diane Proudfoot, Catherine M. Shanahan  Kidney International  Volume 79, Issue 4, Pages 379-382 (February 2011) DOI: 10.1038/ki.2010.455 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Model showing pathways activated in vascular smooth muscle cells in response to elevated phosphate. In this model, uptake of phosphate (P) via Pit-1 may act to drive vascular smooth muscle cell (VSMC) phenotypic change via upregulation of the key transcription factor Runx2. These secretory VSMCs are able to adapt to the conditions, but loss of inhibitors and cell death will promote nanocrystal deposition. Once this occurs, uptake of nanocrystals initiates a new cycle of apoptosis, inflammation, and osteogenic gene expression, with bone morphogenetic protein-2 (BMP-2) able to drive calcification in surrounding cells. MGP, matrix Gla protein. Kidney International 2011 79, 379-382DOI: (10.1038/ki.2010.455) Copyright © 2011 International Society of Nephrology Terms and Conditions